Exascale Labs director reports no XLAB stake

Exascale Labs Holdings Inc. (XLAB) has a new director, David Edward Card, who filed an initial statement of beneficial ownership on Form 3.

Rhea-AI Filing Summary

Exascale Labs Holdings Inc. (XLAB) has a new director, David Edward Card, who filed an initial statement of beneficial ownership on Form 3. The filing reports no transactions and no equity holdings or derivative positions for him as of the reporting date.

Key Figures

Reported buy transactions: 0 transactions Reported sell transactions: 0 transactions Reported derivative transactions: 0 transactions +1 more

4 metrics

Reported buy transactions 0 transactions BuyCount in the Form 3 transaction summary for David Edward Card

Reported sell transactions 0 transactions SellCount in the Form 3 transaction summary for David Edward Card

Reported derivative transactions 0 transactions DerivativeTransactionCount in the Form 3 transaction summary

Post-transaction holdings entries 0 entries HoldingEntries in the Form 3 transaction summary

FAQ

What does the Form 3 filing for XLAB report about David Edward Card?

The Form 3 for Exascale Labs Holdings Inc. (XLAB) reports that director David Edward Card had no reported stock or derivative holdings and no transactions at the time of the filing.

Is David Edward Card an officer of Exascale Labs Holdings Inc. (XLAB)?

No. The Form 3 identifies David Edward Card as a director of Exascale Labs Holdings Inc. (XLAB) and indicates he is not an officer and not a ten percent owner.

Does the XLAB Form 3 show any recent insider buying or selling?

No. The Form 3 transaction summary for Exascale Labs Holdings Inc. (XLAB) shows zero buy transactions, zero sell transactions, and no other reportable transactions for David Edward Card.

Are there any derivative securities reported for David Edward Card in XLAB?

No. The derivative summary for Exascale Labs Holdings Inc. (XLAB) lists no derivative positions such as options or warrants held by David Edward Card in this Form 3.

Does the XLAB Form 3 mention a Rule 10b5-1 trading plan?

No. The Form 3 data for Exascale Labs Holdings Inc. (XLAB) shows the Rule 10b5-1 plan indicator as null, which reflects that no trading-plan status is reported in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 12:36 PM Accepted by SEC EDGAR 09/08/2026 - 12:36 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Card David Edward

(Last) (First) (Middle)

820 GESSNER ROAD, SUITE 332

(Street)

HOUSTON, TEXAS 77024

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
08/27/2026

3. Issuer Name and Ticker or Trading Symbol
Exascale Labs Holdings Inc. [ XLAB ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ David Card	09/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)